Related Experiment Video
Updated: Apr 20, 2026

Digital Home-Monitoring of Patients after Kidney Transplantation: The MACCS Platform
Published on: April 12, 2021
[Impact of a program designed to improve continuous renal replacement therapy stability]
M Page1, T Rimmelé1, J Prothet1
1Service d'anesthésie-réanimation, pavillon P réanimation, hôpital Édouard-Herriot, 5, place d'Arsonval, 69437 Lyon cedex 03, France.
Insights
Implementing a new program significantly reduced unexpected circuit clotting during continuous renal replacement therapy (CRRT), improving filter lifespan and therapy stability.
Area of Science:
- Nephrology and Critical Care Medicine
- Renal Replacement Therapies
- Biomedical Engineering
Context:
- Continuous renal replacement therapy (CRRT) is vital for critically ill patients.
- Circuit clotting is a major complication, increasing workload, costs, and blood loss.
- Improving CRRT stability is crucial for patient outcomes and resource management.
Purpose:
- To evaluate the effectiveness of a multifaceted program aimed at enhancing CRRT stability.
- To assess the program's impact on reducing unexpected circuit clotting events.
- To analyze changes in CRRT filter lifespan post-intervention.
Summary:
- A retrospective observational study analyzed 401 CRRT sessions before (2009-2010) and after (2011-2012) program implementation.
- The program included regional citrate anticoagulation, super high-flux membranes, and specialized nurse training.
- Unexpected CRRT session ends decreased from 40% to 17% (P<0.0001), and median filter life extended from 33 to 55 hours (P<0.0001).
Impact:
- The implemented program successfully reduced unexpected circuit clotting in CRRT.
- Enhanced CRRT stability leads to fewer therapy interruptions and improved filter utilization.
- This intervention offers a potential strategy to optimize CRRT management in intensive care settings.
Objectives:
During continuous renal replacement therapy (CRRT), circuit clotting increases nursing workload, cost of the therapy and blood loss. The aim of this study was to assess the impact of a program designed to improve CRRT stability on unexpected circuit clotting.
Study Design:
Retrospective and observational study.
Patients And Methods:
In January 2011, several changes have been adopted regarding CRRT management. Regional citrate anticoagulation, continuous hemodialysis using super high-flux membranes and a specific training for intensive care unit nurses were implemented. CRRT sessions before (year 2009 and 2010, "Before group") and after (year 2011 and 2012, "After group") were analyzed. The primary endpoint was the incidence of unexpected CRRT session end.
Results:
During the study period, 401 sessions performed in 152 patients were analyzed. Sixty-three unexpected session's end (40%) occurred before and 43 (17%) after the implementation of the program (P<0.0001). Median filter life time was 33 (13-48) hours before and 55 (27-67) hours after (P<0.0001).
Conclusion:
Our program designed to improve CRRT stability reduced filter losses by reducing unexpected circuit clotting.
More Related Videos
03:13Technical Refinement of a Bilateral Renal Ischemia-Reperfusion Mouse Model for Acute Kidney Injury Research
Published on: November 3, 2023
04:37Improved Home Blood Pressure Control by CT-guided Ozone-mediated Renal Denervation for Patients with Resistant Hypertension
Published on: June 6, 2025
Related Concept Videos
Continuous Renal Replacement Therapy
Extracorporeal Removal of Drugs: Continuous Renal Replacement Therapy
Acute Kidney Injury V: Interprofessional Care
Acute Kidney Injury IV: Diagnostic Studies and Prevention
Drug Dosing in Renal Diseases: Dose Adjustments Based on Drug Clearance and Elimination Rate Constant
Renal Failure: Dose Adjustments
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...